Search for: "United States v. Abbott Laboratories" Results 1 - 20 of 154
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Nov 2022, 4:45 pm by Samuel Bray
Professor Harrison's work was recently highlighted by Professor Amanda Frost at SCOTUSBlog as one side of a debate critical to United States v. [read post]
28 Apr 2022, 4:17 pm by Coral Beach
We need to know exactly who in the company was aware of this failure and the alleged attempts to hide this information from the FDA,” DeLauro said during a meeting on the Fiscal Year 2023 Budget Request for the United States Department of Agriculture. [read post]
27 Dec 2021, 7:02 am by Ana Popovich
One example is the May 10 settlement between the U.S. and the University of Miami (UM), which agreed to pay $22 million to resolve allegations that it “routinely ordered medically unnecessary laboratory tests and used misleading billing practices to increase their reimbursement from Medicare,” a WNN article states. [read post]
23 Aug 2021, 2:12 am by Radhi Shah (USC Gould School of Law)
Congress, to exercise March-in rights for patents owned by Abbott laboratories, Inc. [read post]
13 Aug 2021, 2:23 pm by Mitchell Jagodinski
United States 21-171Issue: Whether 18 U.S.C. [read post]
9 Jan 2021, 2:00 pm by Robert Liles
  As UPIC clinical reviewers of both Medicare and Medicaid claims are quick to state in hearings before an Administrative Law Judge, “If it isn’t documented, it didn’t happen. [read post]
2 Nov 2020, 8:09 am by D. Julie Lee
  One such example is asserted in the lawsuit filed by global health care company Abbott Laboratories (“Abbott”) against its former employee Justin Brown in the United States District Court for the Northern District of […] [read post]
24 Apr 2020, 6:58 am by Lisa Larrimore Ouellette
Abbott Laboratories has drawn praise for developing a relatively reliable, fast diagnostic test for COVID-19, but (at least as of mid-April 2020) its manufacturing capacity has been unable to keep up with demand. [read post]
8 Apr 2020, 12:36 pm by Eugene Volokh
Massachusetts (1944) (noting that "[t]he right to practice religion freely does not include liberty to expose the community … to communicable disease"); United States v. [read post]
13 Nov 2019, 10:35 am by Nora Freeman Engstrom, Robert L. Rabin
Abbott Laboratories (1980), which established market share liability for the inter-generational harm traceable to DES, a drug marketed to pregnant women, ostensibly to prevent miscarriage. [read post]
15 Jul 2019, 5:01 am by Eugene Volokh
The Tenth Circuit has not yet ruled on whether such a First Amendment right of access exists in civil cases, see United States v. [read post]
18 Jun 2019, 5:30 am by Bill Marler
To improve surveillance, the Council of State and Territorial Epidemiologists has recommended that all L. monocytogenes isolates be forwarded to state public health laboratories for subtyping through the National Molecular Subtyping Network for Foodborne Disease Surveillance (PulseNet). [read post]
19 Mar 2019, 11:00 pm
The underlying suit was based on Abbott's belief that the defendants were importing, advertising, and subsequently distributing boxes of Abbott's international test strips in the United States. [read post]
9 Nov 2018, 5:31 am
 Mazzo executed a nondisclosure agreement with Abbott Laboratories, Inc. while that firm was exploring its  acquisition of AMO. [read post]
17 Sep 2018, 9:30 pm by Ronald M. Levin
As is well known, pre-enforcement review of rules was not recognized as an option in other APA proceedings until 1967, when the Supreme Court decided Abbott Laboratories v. [read post]